Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Dumping Solazyme Inc (SZYM)

Page 1 of 2

At the moment, there are plenty of gauges Solazyme Inc (NASDAQ:SZYM) investors can use to analyze publicly traded companies. A duo of the best are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the top hedge fund managers can outpace the market by a healthy margin (see just how much).

Just as crucial, bullish insider trading sentiment is another way to look at the financial markets. There are a variety of incentives for a bullish insider to sell shares of his or her company, but only one, very simple reason why they would behave bullishly. Many empirical studies have demonstrated the market-beating potential of this strategy if shareholders know where to look (learn more here).

Thus, we’re going to examine the recent info surrounding Solazyme Inc (NASDAQ:SZYM).

How have hedgies been trading Solazyme Inc (NASDAQ:SZYM)?

Heading into Q3, a total of 9 of the hedge funds we track held long positions in this stock, a change of -18% from the first quarter. With the smart money’s sentiment swirling, there exists a select group of noteworthy hedge fund managers who were upping their stakes substantially.

Solazyme Inc (NASDAQ:SZYM)According to our 13F database, Passport Capital, managed by John Burbank, holds the biggest position in Solazyme Inc (NASDAQ:SZYM). Passport Capital has a $7.2 million position in the stock, comprising 0.2% of its 13F portfolio. On Passport Capital’s heels is William Harnisch of Peconic Partners LLC, with a $3.7 million position; the fund has 0.5% of its 13F portfolio invested in the stock. Remaining hedgies that hold long positions include Michael Platt and William Reeves’s BlueCrest Capital Mgmt., John Murphy’s Alydar Capital and Matthew Hulsizer’s PEAK6 Capital Management.

As Solazyme Inc (NASDAQ:SZYM) has witnessed bearish sentiment from the entirety of the hedge funds we track, we can see that there lies a certain “tier” of funds that elected to cut their positions entirely in Q1. Interestingly, Steven Cohen’s SAC Capital Advisors cut the largest position of all the hedgies we track, valued at an estimated $3.9 million in stock, and Andrew R. Midler of Savitr Capital was right behind this move, as the fund dropped about $1.5 million worth. These bearish behaviors are intriguing to say the least, as aggregate hedge fund interest fell by 2 funds in Q1.

How have insiders been trading Solazyme Inc (NASDAQ:SZYM)?

Bullish insider trading is best served when the company in question has seen transactions within the past 180 days. Over the last 180-day time period, Solazyme Inc (NASDAQ:SZYM) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll also take a look at the relationship between both of these indicators in other stocks similar to Solazyme Inc (NASDAQ:SZYM). These stocks are LSB Industries, Inc. (NYSE:LXU), Aceto Corporation (NASDAQ:ACET), Landec Corporation (NASDAQ:LNDC), Rentech, Inc. (NYSEAMEX:RTK), and FutureFuel Corp. (NYSE:FF). This group of stocks belong to the chemicals – major diversified industry and their market caps match SZYM’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!